{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"95","upperLimit":"100","value":"100"},{"groupId":"OG001","lowerLimit":"85.4","upperLimit":"99.9","value":"94.7"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"19"}],"units":"Participants"}],"description":"To compare overall survival in subjects receiving autologous peripheral blood stem cell transplant after undergoing induction therapy with lenalidomide and dexamethasone versus in those receiving only lenalidomide and dexamethasone, followed by lenalidomide maintenance in both arms. Only patients who achieved at least a partial response (PR) following 4 cycles of induction were included in the analysis.","dispersionType":"95% Confidence Interval","groups":[{"description":"Subjects will receive the current standard of care treatment. Lenalidomide and dexamethasone for four 28-day cycles followed by stem cell collection and autologous peripheral blood stem cell transplant. After 90 days, start the maintenance phase (lenalidomide days 1-21 every 28 days for two years or until your disease progresses).","id":"OG000","title":"Arm A: Low-dose Dexamethasone + Stem Cell Transplantation"},{"description":"Subjects will receive the new treatment that will be compared with the standard of care. Lenalidomide and dexamethasone for eight 28-day cycles. After four cycles your stem cells will be collected (stem cell collection). After an additional four cycles of lenalidomide (a total of 8 cycles), start the maintenance phase (lenalidomide days 1-21 every 28 days for two years or until your disease progresses).\n\nOnly includes subjects who received drug.","id":"OG001","title":"Arm B: Low-dose Dexamethasone"}],"paramType":"NUMBER","populationDescription":"Only patients who achieved at least a partial response (PR) following 4 cycles of induction were included in the analysis.","reportingStatus":"POSTED","timeFrame":"2 years","title":"Overall Survival Rate (OS)","type":"SECONDARY","unitOfMeasure":"percentage of participants"}